OGEN·684023609·US·equity·Healthcare - Biotechnology-13D/G
OGEN (ORAGENICS INC) is held by 10 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($36,445), Pathstone Holdings, LLC ($30,807), UBS Group AG ($2,915). Net institutional sentiment: Mixed.
See how OGEN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer